Pricing Log in Create free account

NervGen Pharma Corp. (NGEN) vs Sionna Therapeutics, Inc. (SION)

NervGen Pharma Corp. and Sionna Therapeutics, Inc. are both Biotechnology companies. NervGen Pharma Corp. and Sionna Therapeutics, Inc. are of similar size ($148.3M and $143.1M). Across the 9 metrics below, Sionna Therapeutics, Inc. leads on 5 and NervGen Pharma Corp. on 4.

Valuation

Metric NGEN SION Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 3.63 0.56 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.57 0.66
EV/Sales n/m n/m 9.02
Earnings yield (17.89%) (66.46%) (32.88%)
Free cash flow yield (14.96%) (51.52%) (23.13%)

Profitability

Metric NGEN SION Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (94.85%) (32.34%) (51.96%)
Return on assets (40.66%) (30.66%) (46.06%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric NGEN SION Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (68.14%) 88.24% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric NGEN SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.07 20.05 4.97
Net debt to EBITDA 0.95 2.58 1.01

Dividend

Metric NGEN SION Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NGEN SION Biotechnology median
Market cap 143.13m 148.30m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack